{"product_id":"laila-14-capsule-molli","title":"Laila 14 soft capsules","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eLaila\u003c\/b\u003e is a traditional medicine of plant origin indicated for the relief of mild anxiety symptoms and to promote sleep. The use of this traditional medicinal product of plant origin, for the indicated therapeutic indications, is based exclusively on many years of experience of use. \u003cb\u003eLaila \u003c\/b\u003eIt is indicated in adults and adolescents aged 12 and over.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e1 soft capsule contains: 80 mg of \u003ci\u003eLavandula angustifolia\u003c\/i\u003e Miller, aetheroleum (lavender essential oil). \u003cu\u003eExcipient with known effects\u003c\/u\u003e: Sorbitol, approx. 12 mg\/soft capsule. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eCapsule contents\u003c\/u\u003e: Refined rapeseed oil. \u003cu\u003eCapsule shell\u003c\/u\u003e: Gelatin succinylate, Glycerol 85%, Non-crystallized sorbitol 70%, Titanium dioxide, Coloring agents: Carminic acid aluminum lake (E 120); Patented blue V aluminum lacquer (E 131).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eDosage \u003c\/b\u003e Adults and adolescents over 12 years of age take one soft capsule per day (corresponding to 80 mg of lavender essential oil per day). \u003ci\u003ePediatric population\u003c\/i\u003e \u003cb\u003eLaila\u003c\/b\u003e must not be used in children under 12 years of age (see section 4.4 Special warnings and precautions for use). \u003cb\u003eMethod of administration \u003c\/b\u003e Oral use. The soft capsules should be swallowed whole with sufficient liquid (preferably a glass of water). \u003cb\u003eDuration of treatment \u003c\/b\u003e If symptoms persist after two weeks of using the product, you should consult a doctor or qualified healthcare practitioner.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDo not store above 30°C.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eUse in children under 12 years has not been established due to insufficient data. If symptoms worsen during use of the product, a doctor or qualified healthcare professional should be consulted. \u003cb\u003eLaila\u003c\/b\u003e contains sorbitol. Patients with rare hereditary problems of fructose intolerance should not take this medicine. Use in patients with impaired liver function is not recommended since the components of lavender essence are largely eliminated by liver metabolism.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003ePublished data demonstrate that in humans lavender essential oil (160 mg\/day) has no clinically relevant effects of inhibition or induction of CYP 1A2, 2C9, 2C19, 2D6 and 3A4 enzymes. Furthermore, no clinically relevant impact of lavender essential oil on the contraceptive efficacy of combined oral contraceptives has emerged.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eGastrointestinal disorders \u003c\/b\u003e Mild gastrointestinal discomfort (e.g. belching). Frequency not known. \u003cb\u003eSkin and subcutaneous tissue disorders \/ Immune system disorders\u003c\/b\u003e Allergic skin reactions. Frequency not known. \u003cb\u003eReporting of suspected adverse reactions \u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at http:\/\/www.agenziafarmaco.gov.it\/content\/come-segnalare-unasospetti-reazione-avversa.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo cases of overdose have been reported.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSafety during pregnancy and breastfeeding has not been established. In the absence of sufficient data, use during pregnancy and breastfeeding is not recommended. No data on fertility are available.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eLaila\u003c\/b\u003e does not or negligibly alter the ability to drive and use machinery.\u003c\/p\u003e","brand":"Dr. Willmar Schwabe","offers":[{"title":"Default Title","offer_id":51730207277383,"sku":"044460018","price":13.49,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/dr-willmar-schwabe-gmbh-co-kg-laila-14-capsule-molli-farmacia-dottor-tili-1213791097.jpg?v=1767140230","url":"https:\/\/www.dottortili.com\/en-eu\/products\/laila-14-soft-capsules","provider":"Farmacia Dottor Tili","version":"1.0","type":"link"}